Clough Capital Partners L P Vertex Pharmaceuticals Inc Call Options Transaction History

Clough Capital Partners L P

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $11 Million - $12.3 Million	60,500 Added 76.1%	140,000 $25.4 Million
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $53.1 Million - $62.6 Million	-283,000 Reduced 78.07%	79,500 $16 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $44 Million - $51.3 Million	212,500 Added 141.67%	362,500 $77.9 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $31.1 Million - $41.4 Million	150,000 New	150,000 $35.5 Million

1,707

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

Stay updated on Clough Capital Partners L P with notifications on news.